| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 2.430 | 2.579 | 2.529 | 620 | 1.617 | 3.447 | 4.043 | 4.021 |
| Total Income - EUR | - | - | 2.430 | 2.579 | 2.529 | 620 | 1.617 | 3.447 | 4.043 | 4.021 |
| Total Expenses - EUR | - | - | 150 | 540 | 367 | 1.824 | 967 | 751 | 1.611 | 1.981 |
| Gross Profit/Loss - EUR | - | - | 2.280 | 2.038 | 2.161 | -1.203 | 650 | 2.696 | 2.432 | 2.040 |
| Net Profit/Loss - EUR | - | - | 2.207 | 1.961 | 2.086 | -1.220 | 603 | 2.605 | 1.949 | 1.624 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Onco Petra Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 2.518 | 2.041 | 2.191 | 910 | 791 | 3.272 | 2.045 | 3.662 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | - | 2.518 | 2.041 | 2.191 | 910 | 791 | 3.272 | 2.045 | 3.662 |
| Shareholders Funds | - | - | 2.251 | 2.021 | 2.172 | 910 | 651 | 3.258 | 1.998 | 1.827 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 292 | 19 | 19 | 0 | 140 | 14 | 47 | 1.835 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7219 - 7219" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Onco Petra Med S.r.l.